High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.4M
$4,393,536
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-04-01 | $156,300 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -75.7%
2026-04-01
$441,904x3
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -75.7%
|
2026-04-01 | $441,904x3 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-03-20 | $156,300 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -41.1%
2026-03-20
$736,439x3
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -41.1%
|
2026-03-20 | $736,439x3 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-03-10 | $312,600 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -98.8%
2026-03-10
$1,513,560Largex2
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -98.8%
|
2026-03-10 | $1,513,560Largex2 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-02-02 | $156,300 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-02-02 | $690,334x4 | S | Form 4 |
|
MAZE
M
Maze Therapeutics, Inc.
Bernstein Harold
• President
Equity Compensation
2026-01-07
$262,126x2
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
Equity Compensation
|
2026-01-07 | $262,126x2 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-01-07 | $1,011,299Large | S | Form 4 |